Tyler Kirtley of Gunderson Dettmer LLP represents leading venture capital firms and private equity funds in structuring, formation and operation. Kirtley provides guidance on funds throughout all phases of fundraising and organizational development. Key matter includes representing OrbiMed in the formation of its $1.86 billion OrbiMed Royalty and Credit Opportunities Fund V.
Legal 500 Editorial commentary
Phone
P +1 617 648 9144
Email
Profile
Social

Accolades

Boston Elite

Profile

Work Department
Fund Formation; Fund Operations and Compliance
Position

Tyler is a partner in our Boston office.

Career

Tyler’s practice focuses on the structuring, formation and operation of venture capital and other private equity funds and their related general partner and management company entities. Tyler counsels funds in all stages of their fundraising and organization, including in preparing offering materials, negotiating with investors regarding fund formation matters, and drafting partnership, limited liability company and other governance agreements. After fundraising, Tyler counsels fund managers on all aspects of day-to-day operations. Tyler represents a number of leading venture capital firms and routinely advises first-time fund managers.

Prior to joining the firm, Tyler was a fund formation associate in the Washington, D.C. office of Hogan Lovells. Tyler holds a J.D. from the University of California, Berkeley, where he graduated as a member of the Order of the Coif and spent a year as a visiting student at Harvard Law School. Tyler received a B.A. from Stanford University. Prior to attending law school, Tyler was a high school math teacher with Teach For America in Oakland, California.

Content supplied by Gunderson Dettmer LLP

Key clients

  • Boston Celtics
  • Boldstart Ventures
  • Breakthrough Energy Ventures
  • Elephant Partners
  • Evolution Equity Partners
  • Health Velocity Capital
  • OrbiMed Advisors
  • Osage University Partners
  • Questa Capital
  • Riot Ventures
  • Spark Capital
  • Vensana Capital

Work highlights

Represented OrbiMed in the formation of its $1.86 billion OrbiMed Royalty and Credit Opportunities Fund V.
Represented Boston Basketball Partners in its definitive agreement to sell the team to an investor group, pending approval, with an initial valuation of $6.1 billion.
Represented Breakthrough Energy Ventures (BEV) in the launch of a new investment seeking to accelerate the global development of long-term aviation fuel solutions that are cost effective, scalable, and have lower emissions than conventional fuels.